Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: Increased susceptibility of Candida species to fluconazole

Microbial Drug Resistance

Volumn 8, Issue 4, 2002, Pages 311-319

  Hsueh, Po Ren ^a   Teng, Lee Jene ^a,b   Yang, Pan Chyr ^a   Ho, Shen Wu ^a,b   Luh, Kwen Tay ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; OLIGONUCLEOTIDE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD SAMPLING; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CHILD; CLONAL VARIATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FUNGAL STRAIN; FUNGUS ISOLATION; HOSPITAL INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; TAIWAN; UNIVERSITY HOSPITAL;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FUNGI; ISSATCHENKIA ORIENTALIS;

EID: 0036922412     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/10766290260469570     Document Type: Article

References (21)

1. Abbas, J., G.P. Bodey, H.A. Hanna, M. Mardani, E. Girgawy, D. Abi-Said D, E. Whimbey, R. Hachem, and I. Raad. 2000. Candida krusei fungemia: An escalating serious infection in immunocompromised patients. Arch. Intern. Med. 160:2659-2664.
2. Berrouane, Y.F., L.A. Herwaldt, and M.A. Pfaller. 1999. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J. Clin. Microbiol. 37:531-537.
3. Chen, Y.C., S.C. Chang, C.C. Sun, L.S. Yang, W.C. Hsieh, and K.T. Luh. 1997. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect. Control. Hosp. Epidemiol. 18:369-375.
4. Chen, Y.C., S.C. Chang, W.C. Hsieh, and K.T. Luh. 1996. In vitro antifungal susceptibilities of Candida species from the blood. Int. J. Antimicrob. Agents 7:217-222.
5. Cuenca-Estrella, M., E. Mellado, T.M. Diaz-Guerra, A. Monzon, and J.L. Rodriguez-Tudela. 2001. Azasordarins: Susceptibility of fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida spp. To GW 471558. Antimicrob. Agents Chemother. 45:1905-1907.
6. Edmond, M.B., S.E. Wallace, D.K. McClish, M.A. Pfaller, R.N. Jones, and R.P. Wenzel. 1999. Nosocomial blood stream infections in United States hospitals: A three-year analysis. Clin. Infect. Dis. 29:239-244.
7. Hsueh, P.R., L.J. Teng, C.C. Hung, J.H. Hsu, P.C. Yang, S.W. Ho, and K.T. Luh. 2000. Molecular evidence for strain dissemination of Penicillium marneffei: An emerging pathogen in Taiwan. J. Infect Dis. 181:1706-1712.
8. Hsueh, P.R., M.L. Chen, C.C. Sun, S.H. Chen, H.J. Pan, L.S. Yang, S.C. Chang, S.W. Ho, C.Y. Lee, W.C. Hsieh, and K.T. Luh. 2002. Emergence of antimicrobial drug resistance of major pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg. Infect. Dis. 8:63-68.
9. Huang, C.C., Y.C. Chen, S.C. Chang, K.T. Luh, and W.C. Hsieh. 1996. Nosocomial candidemia in a university hospital in Taiwan. J. Formos. Med. Assoc. 95:19-28.
10. Levin, A.S., S.F. Costa, N.S. Mussi, M. Basso, S.I. Sinto, C. Machado, D.C. Geiger, M.C. Villares, A.Z. Schreiber, and A.A. Barone, 1998. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and hands of health care workers. Diagn. Microbiol. Infect. Dis. 30:243-249.
11. Maebashi, K., M. Niimi, M. Kudoh, F.J. Fischer, K. Makimura, K. Niimi, R.J. Piper, K. Uchida, M. Arisawa, R.D. Cannon, and H. Yamaguchi. 2001. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. J. Antimicrob. Chemother. 47:527-536.
12. National Committee for Clinical Laboratory Standards. 1997. Reference Method for Broth Microdilution Antifungal Susceptibilty Testing of Yeasts. Approved standards M27-A. National Committee for Clinical Laboratory Standards. Wayne, PA.
13. Pfaller, M.A., D.J. Diekema, R.N. Jones, H.S. Sadder, A.C. Fluit, R.J. Hollis, S.A. Messer, and The Sentry Participant Group. 2001. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 39:3254-3259.
14. Pfaller, M.A., S.A. Messer, R.J. Hollis, R.N. Jones, G.V. Doern, M.E. Brandt, and R.A. Hajjeh. In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and vonconazole. Antimicrob. Agents Chemother. 42:3242-3244.
15. Pfaller, M.A., R.N. Jones, S.A. Messer, M.B. Edmond, and R.P. Wenzel. 1998. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequence of occurrence and antifungal susceptibility in the SCOPE Program. Diagn. Microbiol. Infect. Dis. 30:121-129.
16. Pfaller, M.A., S.R. Lockhart, C. Pujol, J.A. Swails-Wenger, S.A. Messer, M.B. Edmond, R.N. Jones, R.P. Wenzel, and D.R. Soll. 1998. Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates. J. Clin. Microbiol. 36:1519-1529.
17. Rex, J.H., T.J. Walsh, J.D. Sobel, S.C. Filler, P.G. Pappas, W.E. Dismukes WE, and J.E. Edwards. 2000. Practice guidelines for the treatment of candidiasis. Clin. Infect. Dis. 30:662-678.
18. Sheehan, D.J., C.A. Hitchcock, and C.M. Sibley. 1999. Current and emerging azole antifungal agents. Clin. Microbiol. Rev. 12:40-79.
19. Wanger, A., K. Mills, P.W. Nelson, and J.H. Rex. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: Enhance ability to detect amphotericin B-resistant Candida isolates. Antimicrob. Agents Chemother. 39:2520-2522.
20. Wingard, J.R., W.A.G. Merz, M.G. Ronald, T.R. Johnson, J.E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325:1274-1277.
21. Xu, J., A.R. Ramos, R. Vilgalys, and T.G. Mitchell. 2000. Clonal and spontaneous origins of fluconazole resistance in Candida albicans. J. Clin. Microbiol. 38:1214-1220.